v3.25.4
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]            
Revenues, net $ 11,800 $ 233,600 $ 340,100 $ 357,700 $ 401,000 $ 145,800
Cost of revenues 10,570 18,243 22,208 24,733 28,072
Gross profit 1,230 215,357 317,892 332,967 372,928 145,800
Operating Expenses:            
Research and development 2,594,750 1,453,363 7,467,532 5,004,794 5,348,709 4,034,591
General and administrative 1,115,491 1,048,987 4,672,192 4,193,225 6,579,413 11,331,983
Total Operating Expenses 3,710,241 2,502,350 12,139,724 9,198,019 11,928,122 15,366,574
Loss From Operations (3,709,011) (2,286,993) (11,821,832) (8,865,052) (11,555,194) (15,220,774)
Other Income:            
Interest income 57,740 158,547 231,621 497,089 616,077 552,293
Grant income         83,333
Other income 930 566 3,336 150,498 150,850 169,664
Gain on exchange of warrants 1,711,698 1,711,698
Change in fair value of warrant liabilities 612,064 1,036,464 552,536 (837,466) 97,188 3,997,780
Total Other Income 670,734 1,195,577 787,493 1,521,819 2,575,813 4,803,070
Net Loss $ (3,038,277) $ (1,091,416) $ (11,034,339) $ (7,343,233) $ (8,979,381) $ (10,417,704)
Net Loss Per Share - Basic $ (0.33) $ (0.13) $ (1.26) $ (0.96) $ (1.16) $ (2.47)
Net Loss Per Share - Diluted $ (0.33) $ (0.13) $ (1.26) $ (0.96) $ (1.16) $ (2.47)
Weighted Average Common Shares Outstanding - Basic 9,116,172 8,121,499 8,742,085 7,643,437 7,763,932 4,218,347
Weighted Average Common Shares Outstanding - Diluted 9,116,172 8,121,499 8,742,085 7,643,437 7,763,932 4,218,347